Dr. Goldmacher is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
320 Bent St
Cambridge, MA 02141- Is this information wrong?
Summary
- Physician, scientist, executive, and entrepreneur focused on clinical development, medical imaging, artificial intelligence, and biomarker applications, with growing experience in pharmaceutical business development (M&A) and financial strategy.
Education & Training
Temple University Fox School of BusinessMBA, 2012 - 2015
University of Texas Southwestern Medical SchoolClass of 2001, MD, PhD- University of ChicagoBA, Biological Sciences
Certifications & Licensure
MA State Medical License 2007 - 2024
PA State Medical License 2008 - 2009
Publications & Presentations
PubMed
- 36 citationsEarly Readout on Overall Survival of Patients With Melanoma Treated With Immunotherapy Using a Novel Imaging Analysis.Laurent Dercle, Binsheng Zhao, Mithat Gönen, Chaya S Moskowitz, Ahmed Firas, Volkan Beylergil, Dana E Connors, Hao Yang, Lin Lu, Tito Fojo, Richard Carvajal, Sanja Kar...> ;JAMA Oncology. 2022 Mar 1
- 8 citationsDeep learning for classification of pediatric chest radiographs by WHO's standardized methodology.Yiyun Chen, Craig S. Roberts, Wanmei Ou, Tanaz Petigara, Gregory V. Goldmacher, Nicholas S. S. Fancourt, Maria Deloria Knoll> ;Plos One. 2021 Jun 21
- 11 citationsComparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trialFiras S. Ahmed, Laurent Dercle, Gregory V. Goldmacher, Hao Yang, Dana E. Connors, Ying Tang, Sanja Karovic, Binsheng Zhao, Richard D. Carvajal, Caroline Robert, Michae...> ;European Radiology. 2021 Apr 1
- Join now to see all
Journal Articles
- Response Criteria for Intratumoral Immunotherapy in Solid Tumors: itRECISTGregory V. Goldmacher, MD, PhD, MBA; Anuradha D. Khilnani, MD; Robert H. I. Andtbacka, MD; Jason J. Luke, MD; F. Stephen Hodi, MD; Aurelien Marabelle, MD, PhD; Kevin H..., Journal of Clinical Oncology, 6/18/2020
Press Mentions
Gregory Goldmacher, MD, PhD, MBA, on New Response Criteria for Intratumoral ImmunotherapyAugust 6th, 2020
Committees
- Co-chair, Immunotherapy Subcommittee, RECIST Working Group 2021 - Present
- Steering committee, Pharmaceutical Imaging Network for Therapeutics and Diagnostics (PINTAD)
- Steering Committee, Modality Committee Co-Chair, CT Volumetry Committee Co-Chair, Quantitative Imaging Biomarkers Alliance
Professional Memberships
- Member
- Member
Other Languages
- Russian, French, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
